Renal Cancer - Results from #5760

Combination therapy for metastatic renal cell carcinoma April 13, 2016

Heritable Cancer Syndromes Related to the Hypoxia Pathway April 13, 2016

Germline mutations in the VHL gene associated with three different renal lesions in a Chinese von Hippel-Lindau disease family April 12, 2016

Potentially curable recurrent disease after surgically managed non-metastatic renal cell carcinoma in low-, intermediate- and high-risk patients April 12, 2016

A patient with Multiple myeloma and Renal cell carcinoma April 12, 2016

Safety assessment of molecular targeted therapies in association with radiotherapy in metastatic renal cell carcinoma: a real-life report April 12, 2016

Risk of recurrence and conditional survival in complete responders treated with TKIs plus or less locoregional therapies for metastatic renal cell carcinoma April 12, 2016

Response to post-axitinib treatment in patients with metastatic renal cell carcinoma April 12, 2016

Oligometastatic state predicts a favorable outcome for renal cell carcinoma patients with bone metastasis under the treatment of Sunitinib April 11, 2016

Combining miRNA and mRNA Expression Profiles in Wilms Tumor Subtypes April 11, 2016

Response and tolerability of a single dose of 177Lu-PSMA-617 in patients with metastatic castration-resistant prostate cancer: a multicenter retrospective analysis April 10, 2016

Recurrence rates and survival in a Danish cohort with renal cell carcinoma April 8, 2016

Epigenomics of clear cell renal cell carcinoma: mechanisms and potential use in molecular pathology April 8, 2016

Pathological Upstaging of Clinical T1 to pT3a Renal Cell Carcinoma: A Multi-Institutional Analysis of Short-Term Outcomes April 6, 2016

Hormone signaling pathways as treatment targets in renal cell cancer (Review) April 5, 2016

Galangin inhibits cell invasion by suppressing the epithelial-mesenchymal transition and inducing apoptosis in renal cell carcinoma April 5, 2016

Simvastatin Reduces Cancerogenic Potential of Renal Cancer Cells via Geranylgeranyl Pyrophosphate and Mevalonate Pathway April 5, 2016

Phase 2 Study of Bevacizumab and Temsirolimus After VEGFR TKI in Metastatic Renal Cell Carcinoma April 4, 2016

The Role Of Metastasectomy In Patients With Renal Cell Carcinoma With Sarcomatoid Dedifferentiation: A Matched Controlled Analysis April 4, 2016

A study on the association between hyperlipidemia and hypothyroidism and the response to TKIs in metastatic renal cell carcinoma April 1, 2016

Page 289 of 456